Cediranib (AZD2171), 10mM/1mL

Cediranib (AZD2171), 10mM/1mL

Dovitinib (TKI-258), 50mg

Dovitinib (TKI-258), 50mg

Dovitinib (TKI-258), 10mg

1.331,61 RON
SKU
SKM_S1018_10mg

Dovitinib (TKI258, CHIR258) is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGF-1R and HER2 in cell-free assays. Phase 4.

Mai multe informatii
Price 1.119,00 RON (preturile sunt fara TVA)
Description

Dovitinib (TKI258, CHIR258) is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGF-1R and HER2 in cell-free assays. Phase 4.